Supriya Lifescience Limited

Supriya Lifescience Limited

Supriya Lifescience Limited
listed
₹14,310Min. investment
  1. Bid start
    16 Dec
  2. Bid end
    20 Dec
  3. Allotment
    18 Dec
  4. Release of funds
    24 Dec
  5. Demat transfer
    23 Dec
  6. Listing
    28 Dec

About Supriya Lifescience Limited

Price range₹265 – ₹274
IPO type
Regular
Lot size54 shares
Issue size₹700Cr
RHP/DRHP
Read

Checklist

Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
From being incorporated in 1987 as a partnership firm which makes chemicals, Supriya Lifescience has evolved into one of the key manufacturers and suppliers of active pharmaceutical ingredients (APIs). Also, over the last three years, the company has posted strong financial performance. Its revenue and profit have risen steadily, aided by growth in domestic and export pharma markets. This API manufacturer is now all set to launch its ₹700 crore IPO and list on the exchanges.
Key highlights
  • Has niche 38 APIs which are used in diverse therapeutic segments including antihistamine, analgesic and anaesthetic 
  • As of October 2021, its products were exported to 1,296 clients across 86 countries
  • Around 77% of its revenue came from exports in FY21
Strengths
  • Accounted for 45-55% and 65-70%, respectively, of the Chlorpheniramine Maleate and Ketamine Hydrochloride exports from India between FY17-FY21
  • Increased share in Salbutamol Sulphate exports from 25-30% in FY17 to 35-40% in FY21
  Risks
  • Operates in a highly regulated industry. Facilities and products are subject to periodic inspections or audits
  • High dependence on its 10 APIs, which account for over 80% of revenue
Opportunities
  • The global pharmaceutical market is expected to grow at a CAGR of 6% to ₹1,730 billion by 2025 
  • The domestic formulations market is expected to grow at a CAGR of 11% over the next five years  

Frequently asked questions

How to invest in the IPO?

Investors can apply for the IPO through their Demat account via the stock exchange or through their broker.

What is the issue size of Supriya Lifescience Limited ?

The issue size of the Supriya Lifescience Limited is 700 Cr.

What is 'pre-apply' for Supriya Lifescience Limited ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Supriya Lifescience Limited shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.